US Broker Ratings

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

Chemed Corp (CHE) Stock Analysis: Exploring a 14.81% Upside Potential

Chemed Corp (CHE), an influential player in the healthcare sector, stands at an intriguing junction for investors seeking steady returns and potential growth. With a current market capitalization of $5.31..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 37% Potential Upside with Robust Pipeline

Insmed Incorporated (NASDAQ: INSM) stands as a notable player in the biotechnology sector, offering a compelling investment opportunity characterized by a strong pipeline of therapies for serious and rare diseases...

Qiagen N.V. (QGEN) Stock Report: Exploring a 35.64% Potential Upside in the Diagnostics Sector

As individual investors navigate the complexities of the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) emerges as a noteworthy player in the Diagnostics & Research industry. With a market capitalization of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Strong 32% Revenue Increase

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing investor attention with its substantial growth trajectory. As..

Abbott Laboratories (ABT) Stock Analysis: Unveiling a 31% Potential Upside for Savvy Investors

Abbott Laboratories (NYSE: ABT), a venerable name in the healthcare sector, continues to be a compelling prospect for investors seeking both stability and growth. With its current market cap standing..

Bristol-Myers Squibb (BMY) Investor Outlook: A Look at Its 4.30% Dividend Yield and Growth Potential

For investors with an eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust dividend yield and potential for growth. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unveiling a 24% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry, stands out in the healthcare sector with its innovative cardiovascular solutions. Headquartered in Irvine, California, the company has..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 15.19% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers investors an intriguing opportunity for growth. With a market capitalization of $11.96 billion, this Ireland-based company has..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 32.58% Upside for Investors

Bio-Techne Corp (NASDAQ: TECH) stands as a key player in the biotechnology sector, developing and manufacturing life science reagents, instruments, and services for global markets. With a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 53% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing the attention of investors with a significant potential upside..

Insulet Corporation (PODD) Stock Analysis: Strong Growth Potential with a 72.78% Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in the development and sale of innovative insulin delivery systems. With a current market capitalization of $13.86 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 31.89% Upside Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a titan in the healthcare sector specializing in diagnostics and research, commands a significant presence in the veterinary diagnostics market. With a market capitalization of..

BioNTech SE (BNTX) Stock Analysis: Navigating a Complex Valuation with Promising Upside

BioNTech SE (NASDAQ: BNTX), a pioneer in the biotechnology space, has garnered significant attention for its role in developing mRNA-based therapies. With a market capitalization of $24.15 billion, this German..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing a 38.79% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, continues to capture investor attention with its extensive portfolio of clinical research services and healthcare intelligence solutions. The..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Analyzing the 16.90% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, has consistently positioned itself as a leader in the healthcare industry with its innovative treatments and robust pipeline...

argenx SE (ARGX) Investor Outlook: Navigating a Promising 28.89% Upside in Biotech

argenx SE (ARGX), a leading name in the biotechnology sector, is captivating investor attention with its robust market presence and promising growth prospects. Headquartered in the Netherlands, this commercial-stage biopharma..

Elevance Health, Inc. (ELV) Stock Analysis: A 22% Upside Potential Amidst Solid Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare sector, is currently drawing attention from the investment community. With a market capitalization of $68.76 billion, Elevance operates a broad..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a Promising 82.86% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a key player in the medical instruments and supplies industry, is turning heads among investors with a compelling 82.86% potential upside. With a market capitalization..

AptarGroup, Inc. (ATR) Stock Analysis: Unlocking a 23.74% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leader in the medical instruments and supplies industry, presents an enticing opportunity for investors looking for stable growth and reliable dividends within the healthcare sector...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds